Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03428802
Brief Title: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

First Submitted : February 5, 2018
First Submitted that Met QC Criteria : February 5, 2018
First Posted : February 12, 2018

Last Update Submitted that Met QC Criteria : October 17, 2019
Last Update Posted : October 18, 2019